IKT Operating Cash Flow (Statement)
Inhibikase Therapeutics Inc · Operating Cash Flow (Statement)
IKT Operating Cash Flow (Statement)
Latest reported-$42.61Mperiod ending
IKT TTM Cash from Operations (-$338.29K → -$42.61M)
TTM operating cash flow (statement)
High-resolution chart · PNG
IKT operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -42,612,037 | |
| -35,742,656 | |
| -27,786,464 | |
| -25,616,066 | |
| -19,904,436 | |
| -19,384,579 | |
| -19,148,067 | |
| -17,244,923 | |
| -16,468,916 | |
| -15,979,931 | |
| -18,085,043 | |
| -18,198,986 | |
| -19,598,623 | |
| -19,389,036 | |
| -17,351,103 | |
| -17,890,546 | |
| -14,406,314 | |
| -14,297,028 | |
| -14,297,051 | |
| -11,147,762 | |
| -9,051,749 | |
| -4,815,902 | |
| -1,137,114 | |
| -184,213 | |
| -266,529 | |
| -305,000 | |
| -338,290 | |
| -280,711 | |
| -179,812 |